Home > Balance Sheet > WINDLAS BIOTECH

WINDLAS BIOTECH
Total Non-Current Liabilities

    Back to Balance Sheet
WINDLAS BIOTECH is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹4.95 Cr₹3.95 Cr₹3.44 Cr₹0.21 Cr₹3.59 Cr

What is the latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH ?

The latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH is ₹4.95 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹4.95 Cr
Mar2024₹3.95 Cr
Mar2023₹3.44 Cr
Mar2022₹0.21 Cr
Mar2021₹3.59 Cr

How is Total Non-Current Liabilities of WINDLAS BIOTECH Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹4.95 Cr
25.46
Mar2024 ₹3.95 Cr
14.84
Mar2023 ₹3.44 Cr
1,513.62
Mar2022 ₹0.21 Cr
-94.06
Mar2021 ₹3.59 Cr -

Compare Total Non-Current Liabilities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,849.0 Cr 4.5% 15.2% -11.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 0.1% -3.2% -2.6% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr -1.5% -7.3% 2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -0.7% 24.4% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -8.1% -6.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 3.2% 5.6% 3.1% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

4.5%

15.2%

-11.4%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses